Medicus Pharma Celebrates Nasdaq Anniversary with Opening Bell Ceremony

Medicus Pharma, a biotech company, celebrated its one-year anniversary on the Nasdaq exchange with an opening bell ceremony. The company's CEO, Dr. Raza Bokhari, highlighted the milestone as a reflection of Medicus' progress and focus on advancing its clinical portfolio. Medicus' pipeline includes SkinJect for basal cell carcinoma and Teverelix for prostate cancer, with an estimated combined market opportunity of $6 billion. The company also announced a reduced royalty rate for Teverelix, making it more attractive for future partnering.